Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.

There are currently over 2.5 million breast cancer survivors in the United States and, according to the American Cancer Society, 10 to 20 percent of these women will develop recurrent breast cancer. Early detection of recurrence can avoid unnecessary radical treatment. However, self-examination or m...

Full description

Bibliographic Details
Main Authors: Wenrui Hao, Avner Friedman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4831695?pdf=render